FDA warns of severe itching risk when stopping long-term use of allergy medications cetirizine and levocetirizine, affecting quality of life for some users.

The FDA identified 209 cases worldwide (197 in the U.S.) of new-onset pruritus after cetirizine/levocetirizine withdrawal between April 2017 and July 2023.

Awards. DEI Awards; Innovation Awards; Resources. Webinars; Fierce Events; Industry Events; Podcasts; Survey ...

Two antihistamines, including Zyrtec, are under warning by the FDA after people reported “severe itching” after ceasing long-term use of the drugs—what to know.

Cetirizine ophthalmic solution 0.24% (Zerviate) is the first topical ocular formulation of the antihistamine for treatment of ocular itching associated with allergic conjunctivitis.

PRINCETON, N.J., Dec. 31 /PRNewswire/ -- Ranbaxy Laboratories Limited (RLL), announced today that the company has received final approval from the U.S. Food and Drug Administration to manufacture and ...

The US Food and Drug Administration (FDA) is warning that patients who stop taking cetirizine (Zyrtec) or levocetirizine (Xyzal) after long-term use may experience rare but severe itching. The ...

When treating mild allergic reactions, allergists and pediatricians prefer children’s Zyrtec over children’s Benadryl. OTC allergy medications cannot treat extreme allergic reactions ...